These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 26314479)

  • 21. Cost-effectiveness of MRE versus VCTE in staging fibrosis for nonalcoholic fatty liver disease (NAFLD) patients with advanced fibrosis.
    Sangha K; Chang ST; Cheung R; Deshpande VS
    Hepatology; 2023 May; 77(5):1702-1711. PubMed ID: 37018145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimal cut-offs of vibration-controlled transient elastography and magnetic resonance elastography in diagnosing advanced liver fibrosis in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis.
    Chon YE; Jin YJ; An J; Kim HY; Choi M; Jun DW; Kim MN; Han JW; Lee HA; Yu JH; Kim SU
    Clin Mol Hepatol; 2024 Sep; 30(Suppl):S117-S133. PubMed ID: 39165159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two-Step Strategy, FIB-4 Followed by Magnetic Resonance Elastography, for Detecting Advanced Fibrosis in NAFLD.
    Tamaki N; Imajo K; Sharpton SR; Jung J; Sutter N; Kawamura N; Yoneda M; Valasek MA; Behling C; Sirlin CB; Kurosaki M; Izumi N; Nakajima A; Loomba R
    Clin Gastroenterol Hepatol; 2023 Feb; 21(2):380-387.e3. PubMed ID: 35123096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct Comparison of US and MR Elastography for Staging Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
    Imajo K; Honda Y; Kobayashi T; Nagai K; Ozaki A; Iwaki M; Kessoku T; Ogawa Y; Takahashi H; Saigusa Y; Yoneda M; Kirikoshi H; Utsunomiya D; Aishima S; Saito S; Nakajima A
    Clin Gastroenterol Hepatol; 2022 Apr; 20(4):908-917.e11. PubMed ID: 33340780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnetic resonance elastography is superior to acoustic radiation force impulse for the Diagnosis of fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease: A prospective study.
    Cui J; Heba E; Hernandez C; Haufe W; Hooker J; Andre MP; Valasek MA; Aryafar H; Sirlin CB; Loomba R
    Hepatology; 2016 Feb; 63(2):453-61. PubMed ID: 26560734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Characteristics of a Non-Alcoholic Fatty Liver Disease Population Across the Fibrosis Spectrum Measured by Magnetic Resonance Elastography: Analysis of Screening Data.
    Andersen G; Plum-Mörschel L; Hockings PD; Morsing A; Palle MS; Svolgaard O; Flint A
    Adv Ther; 2020 Dec; 37(12):4866-4876. PubMed ID: 33006125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association Between Obesity and Discordance in Fibrosis Stage Determination by Magnetic Resonance vs Transient Elastography in Patients With Nonalcoholic Liver Disease.
    Caussy C; Chen J; Alquiraish MH; Cepin S; Nguyen P; Hernandez C; Yin M; Bettencourt R; Cachay ER; Jayakumar S; Fortney L; Hooker J; Sy E; Valasek MA; Rizo E; Richards L; Brenner DA; Sirlin CB; Ehman RL; Loomba R
    Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1974-1982.e7. PubMed ID: 29104128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.
    Imajo K; Kessoku T; Honda Y; Tomeno W; Ogawa Y; Mawatari H; Fujita K; Yoneda M; Taguri M; Hyogo H; Sumida Y; Ono M; Eguchi Y; Inoue T; Yamanaka T; Wada K; Saito S; Nakajima A
    Gastroenterology; 2016 Mar; 150(3):626-637.e7. PubMed ID: 26677985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnetic resonance elastography is accurate in detecting advanced fibrosis in autoimmune hepatitis.
    Wang J; Malik N; Yin M; Smyrk TC; Czaja AJ; Ehman RL; Venkatesh SK
    World J Gastroenterol; 2017 Feb; 23(5):859-868. PubMed ID: 28223730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis.
    Xiao G; Zhu S; Xiao X; Yan L; Yang J; Wu G
    Hepatology; 2017 Nov; 66(5):1486-1501. PubMed ID: 28586172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective comparison of transient, point shear wave, and magnetic resonance elastography for staging liver fibrosis.
    Lefebvre T; Wartelle-Bladou C; Wong P; Sebastiani G; Giard JM; Castel H; Murphy-Lavallée J; Olivié D; Ilinca A; Sylvestre MP; Gilbert G; Gao ZH; Nguyen BN; Cloutier G; Tang A
    Eur Radiol; 2019 Dec; 29(12):6477-6488. PubMed ID: 31278577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visco-Elastic Parameters at Three-Dimensional MR Elastography for Diagnosing Non-Alcoholic Steatohepatitis and Substantial Fibrosis in Mice.
    Khalfallah M; Doblas S; Hammoutene A; Julea F; Postic C; Valla D; Paradis V; Garteiser P; Van Beers BE
    J Magn Reson Imaging; 2024 Jan; 59(1):97-107. PubMed ID: 37158252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Combination of MR Elastography and Proton Density Fat Fraction Improves Diagnosis of Nonalcoholic Steatohepatitis.
    Alsaqal S; Hockings P; Ahlström H; Gummesson A; Hedström A; Hulthe J; Johansson L; Niessen HG; Schoelch C; Schultheis C; Vessby J; Wanders A; Rorsman F; Ebeling Barbier C
    J Magn Reson Imaging; 2022 Aug; 56(2):368-379. PubMed ID: 34953171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MR elastography in nonalcoholic fatty liver disease: inter-center and inter-analysis-method measurement reproducibility and accuracy at 3T.
    Tang A; Dzyubak B; Yin M; Schlein A; Henderson WC; Hooker JC; Delgado TI; Middleton MS; Zheng L; Wolfson T; Gamst A; Loomba R; Ehman RL; Sirlin CB
    Eur Radiol; 2022 May; 32(5):2937-2948. PubMed ID: 34928415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost Effectiveness of Different Strategies for Detecting Cirrhosis in Patients With Nonalcoholic Fatty Liver Disease Based on United States Health Care System.
    Vilar-Gomez E; Lou Z; Kong N; Vuppalanchi R; Imperiale TF; Chalasani N
    Clin Gastroenterol Hepatol; 2020 Sep; 18(10):2305-2314.e12. PubMed ID: 32289535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic accuracy and clinical impact of MRI-based technologies for patients with non-alcoholic fatty liver disease: systematic review and economic evaluation.
    Bresnahan R; Duarte R; Mahon J; Beale S; Chaplin M; Bhattacharyya D; Houten R; Edwards K; Nevitt S; Maden M; Boland A
    Health Technol Assess; 2023 Jul; 27(10):1-115. PubMed ID: 37839810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Magnetic resonance elastography for the detection and staging of liver fibrosis in chronic hepatitis B.
    Venkatesh SK; Wang G; Lim SG; Wee A
    Eur Radiol; 2014 Jan; 24(1):70-8. PubMed ID: 23928932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Magnetic resonance elastography (MRE) outperforms acoustic force radiation impulse (ARFI) in predicting oesophageal varices in obese NAFLD cirrhosis.
    Roy A; Verma N; Jajodia S; Goenka U; Tiwari A; Sonthalia N; Goenka M
    Abdom Radiol (NY); 2024 Sep; 49(9):3088-3095. PubMed ID: 38652124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transient Elastography Is the Best-Performing Non-Invasive Test of Liver Fibrosis in Obese Asian Patients with Non-Alcoholic Fatty Liver Disease: A Pilot, Cross-Sectional Study.
    Kalaiyarasi K; Sanchalika A; Hsien Min L; Wei Ming Y; Vishalkumar S; Kuo Chao Y; Jee Keem L; Sameer J; Terence HCW; Yen Ping T
    Medicina (Kaunas); 2024 Jan; 60(1):. PubMed ID: 38256429
    [No Abstract]   [Full Text] [Related]  

  • 40. A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes.
    Ajmera V; Cepin S; Tesfai K; Hofflich H; Cadman K; Lopez S; Madamba E; Bettencourt R; Richards L; Behling C; Sirlin CB; Loomba R
    J Hepatol; 2023 Mar; 78(3):471-478. PubMed ID: 36410554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.